Medical Equipment

Versius adopted for gynaecological and urogynaecological procedures at Frances Perry House

* Versius has been introduced at Frances Perry House, a private women's hospital inMelbourne to offer patients access to the benefits of robotic surgery for complex cases including hysterectomies CAMBRIDGE, England, Dec. 13, 2022 /PRNewswire/ -- CMR Surgical – the glo...

2022-12-13 07:00 3489

Frost & Sullivan Recognizes VitalConnect with the 2022 New Product Innovation Award for Its Leading-edge Wearable Patient Monitoring Device

VitalConnect delivers a cost-effective, 24/7 remote patient monitoring platform that outperforms existing patient monitoring devices on the market. SAN ANTONIO, Texas, Dec. 12, 2022 /PRNewswire/ -- Based on its recent analysis of the wearable biosensor industry,Frost & Sullivan recognizes VitalC...

2022-12-12 22:00 2996

SmartCardia Earns Frost & Sullivan's 2022 Global New Product Innovation Award in the Cardiac-monitoring Wearables Industry

The company's innovative real-time monitoring system ensures that patients are treated effectively and efficiently. SAN ANTONIO, Dec. 9, 2022 /PRNewswire/ -- Based on its recent analysis of the cardiac-monitoring wearables market,Frost & Sullivan recognizes SmartCardia with the 2022 Global New P...

2022-12-09 18:00 3331

SonarMed™ airway monitoring system Applauded by Frost & Sullivan for Providing Real-time Visualization for Accurate Troubleshooting with Its Endotracheal Tube Airway Monitor

The SonarMed™ system is the first and only FDA-cleared airway monitoring system that provides heightened patient safety, cost savings, and quality measures while lowering average LOS in the NICU. SAN ANTONIO, Dec. 8, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the neonatal care indus...

2022-12-08 21:00 2679

HARRISON.AI NAMED ON THE 2022 CB INSIGHTS' DIGITAL HEALTH 150 LIST

The clinician-led technology platform has been recognized for achievements in computer-aided imaging NEW YORK, Dec. 8, 2022 /PRNewswire/ -- CB Insights today named harrison.ai to its fourth-annualDigital Health 150

2022-12-08 06:00 3199

BSR KOREA Introduces "Wizbiosolutions Inc." as "2022 Global Procurement Marketer"

SEOUL, South Korea, Dec. 7, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the inter...

2022-12-08 00:00 3278

SmartFuture launches SDK to enable plug-and-play Remote Patient Monitoring in existing healthcare payer and provider applications

SINGAPORE, Dec. 7, 2022 /PRNewswire/ -- SmartFuture, a leading health-tech company and provider of integrated RPM (Remote Patient Monitoring) solutions, has launched anRPM SDK (Software Development Kit) product. SmartFuture's RPM SDK product allows healthcare providers and payers to integrate wh...

2022-12-07 10:36 3597

Veeva Pulse Shows Digitally Enabled Field Teams are Using HCP Time More Effectively in Asia Pacific

HCP Access is selective as nearly half meet with only one company monthly SINGAPORE, Dec. 7, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings from the latestVeeva Pulse Field Trends Report , the largest glob...

2022-12-07 08:00 4593

Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022

WASHINGTON, Dec. 6, 2022 /PRNewswire/ -- TIANGEN, a high-tech biological enterprise, demonstrated its revolutionary nucleic acid extraction solution at Cell Bio 2022, the joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), fromDec 4 to...

2022-12-06 21:04 2647

CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL

Corvia® Atrial Shunt has the potential to change the way heart failure is treated TEWKSBURY, Mass., Dec. 6, 2022 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), announced the first patient has been randomized in RESPONDER-HF, a globa...

2022-12-06 20:04 2178

BSR KOREA Introduces "Healcerion Co., Ltd." as "2022 Global Procurement Marketer"

SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the inter...

2022-12-06 11:00 3575

BSR KOREA Introduces "CORE VALUE" as "2022 Global Procurement Marketer"

SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the inter...

2022-12-06 11:00 2992

Neeuro and Institute of Mental Health Launch Home-Based Attention Training Programme

SINGAPORE, Dec. 6, 2022 /PRNewswire/ -- Neeuro, a Singapore tech start-up and Agency for Science, Technology and Research (A*STAR) spinoff, and the Institute of Mental Health (IMH) launched Cogo as a complementary home-based attention training programme this month. This solution aims to improve i...

2022-12-06 09:00 7657

Medical Metaverse Company, apoQlar, Receives FDA 510(k) Clearance for its Mixed Reality Surgical Planning Platform, VSI HoloMedicine®

HAMBURG, Germany, Dec. 5, 2022 /PRNewswire/ -- apoQlar, a German medical technology company, today announced it has received FDA 510(k) Class II clearance for VSI HoloMedicine®, a pioneering mixed reality software device enabling surgeons to plan complex procedures using the power of immersive 3D...

2022-12-05 21:00 3110

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

NEW YORK and LONDON, Dec. 5, 2022 /PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp ("Iris") (Nasdaq: IRAA), a publicly traded special purpose acquisition company ...

2022-12-05 20:00 2844

Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022

Poster session features a preliminary study result of potential seizure monitoring and detection for patients using SK Biopharmaceuticals' wearable device SK Biopharmaceuticals, Seoul National University Bundang Hospital plan to use Zero WiredTM to further pursue clinical research and develop it...

2022-12-05 08:00 2734

Qilu Pharmaceutical Releases Latest Results of QL1604 plus Chemotherapy as First-Line Treatment for Patients with Advanced Cervical Cancer in the Phase II Study at ESMO Asia Congress 2022

JINAN, China, Dec. 4, 2022 /PRNewswire/ -- Qilu Pharmaceutical, one of the leading vertically integrated pharmaceutical companies inChina that develops, manufactures, and distributes both finished formulations and Active Pharmaceutical Ingredients, announced that the results of the phase II study...

2022-12-04 17:00 2184

JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential

SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing the potential for 3D imaging and AI to be the future of cancer pathology. Presently, most cancer diagnosis is done through thinly sliced physic...

2022-12-03 09:58 3300

Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus

SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- Lakeshore Acquisition I Corp. (Nasdaq: LAAA) ("Lakeshore") today announced that its shareholders have approved all proposals related to the previously announced business combination (the "Business Combination") with ProSomnus Holdings, Inc. ("ProSomnus"...

2022-12-03 05:05 4838

Epiprotect reduces the cost for treatment of hard to heal leg ulcers with 83%

LINKÖPING, Sweden, Dec. 3, 2022 /PRNewswire/ -- A compilation of data from patients treated at S2Clinic during the period 2019-2022 showed that the cost of treatment of these patients was reduced by approximately 83% compared to conventional treatment. The treatment with Epiprotect also resulted ...

2022-12-03 00:41 3630
1 ... 114115116117118119120 ... 148